Post-treatment follow-up study of abdominal cystic echinococcosis in Tibetan communities of Northwest Sichuan province, China

PLoS Neglected Tropical Diseases

Volumn 5, Issue 10, 2011, Pages

  Li, Tiaoying ^a,b   Ito, Akira ^c   Pengcuo, Renqing ^d   Sako, Yasuhito ^c   Chen, Xingwang ^a   Qiu, Dongchuan ^a   Xiao, Ning ^a   Craig, Philip S ^b  

^a Sichuan Center for Disease Control and Prevention   (China)

^b UNIVERSITY OF SALFORD   (United Kingdom)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d Shiqu County Center for Diseases Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT ANTIGEN; ANTHELMINTIC AGENT; HELMINTH ANTIBODY; IMMUNOGLOBULIN G;

ABDOMINAL INFECTION; ADULT; AGED; ALOPECIA; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CHILD; CHINA; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GENERAL CONDITION IMPROVEMENT; HEADACHE; HUMAN; LIVER HYDATID CYST; LIVER PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCHOOL CHILD; PROSPECTIVE STUDY; SEROCONVERSION; STOMACH PAIN; TREATMENT DURATION; ADOLESCENT; ANIMAL; BLOOD; DRUG EFFECT; DRUG MONITORING; ECHINOCOCCUS GRANULOSUS; ENDEMIC DISEASE; IMMUNOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS GRANULOSUS; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; TIBET; TREATMENT OUTCOME; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 80055100232     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001364     Document Type: Article

References (43)

1. Pawlowski ZS, Eckert J, Vuitton DA, Ammann RW, Kern P, et al. (2001) Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern In: Eckert J, Gemmell M, Meslin F-X, Pawlowski Z, editors. Paris World Organisation for Animal Health pp. 20-59.
2. Zhang W, McManus DP, (2006) Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol 47: 24-41.
3. Verastegui M, Moro P, Guevara A, Rodriguez T, Miranda E, et al. (1992) Enzyme-linked immunoelectrotransfer blot test for diagnosis of human hydatid disease. J Clin Microbiol 30: 1557-1561.
4. Cohen H, Paolillo E, Bonifacino R, Botta B, Parada L, et al. (1998) Human cystic echinococcosis in a Uruguayan community: a sonographic, serologic, and epidemiologic study. Am J Trop Med Hyg 59: 620-627.
5. Ortona E, Rigano R, Margutti P, Notargiacomo S, Ioppolo S, et al. (2000) Native and recombinant antigens in the immunodiagnosis of human cystic echinococcosis. Parasite Immunol 22: 553-559.
6. Moro P, Garcia HH, (2005) Screening for cystic echinococcosis in an endemic region of Peru using portable ultrasonography and the enzyme-linked immunoelectrotransfer blot (EITB) assay. Parasitol Res 96: 242-246.
7. Eckert J, Deplazes P, (2004) Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol 17: 107-135.
8. McManus DP, Zhang W, Li J, Bartley PB, (2003) Echinococcosis. Lancet 362: 1295-1304.
9. Brunetti E, Junghanss T, (2007) Update on cystic hydatid disease. Curr Opin Infect Dis 22: 497-502.
10. World Health Organzition (1996) Guidelines for treatment of cystic and alveolar echinococcosis. WHO Informal Working Group on Echinococcosis. Bull World Health Organzition 74: 231-242.
11. Junghanss T, Da Silva AM, Horton J, Chiodini PL, Brunetti E, (2008) Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg 79: 301-311.
12. Brunetti E, Kern P, Vuitton DA, Writing Panel for the WHO-IWGE (2010) Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 114: 1-16.
13. Stojkovic M, Zwahlen M, Teggi A, Vutova K, Cretu CM, (2009) Treatment response of cystic echinococcosis to benzimidazole: a systematic review. PloS Negl Trop Dis 3: 1-10.
14. Wen H, New RR, Craig PS, (1993) Diagnosis and treatment of human hydatidosis. Br J Clin Pharmacol 35: 565-574.
15. Sbihi Y, Janssen D, Osuna A, (1996) Serologic recognition of hydatid cyst antigens using different purification methods. Diagn Microbiol Infect Dis 24: 205-211.
16. Gadea I, Ayala G, Diago MT, Cunat A, Garcia De Lomas J, (2000) Immunological diagnosis of human hydatid cyst relapse: utility of the inzyme-linked immunoeclectrotransfer blot and discriminant analysis. Clin Diagn Lab Immunol 7: 549-552.
17. Doiz O, Benito R, Gil J, Rojas A, Rubio MC, et al. (2002) Pre- and post-surgical detection of IgG, IgM, and IgA specific to hydatidosis by ELISA with purified antigen enriched with the 5/B antigen complex. J Clin Lab Anal 16: 295-298.
18. Rigano R, Ioppolo S, Ortona E, Margutti P, Profumo E, et al. (2002) Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates. Clin Exp Immunol 129: 485-492.
19. Lawn SD, Bligh J, Craig PS, Chiodini PL, (2004) Human cystic echinococcosis: evaluation of post-treatment serologic follow-up by IgG subclass antibody detection. Am J Trop Med Hyg 70: 329-335.
20. Ben Nouir N, Nunez S, Gianinazzi C, Gorcii M, Muller N, et al. (2008) Assessment of Echinococcus granulosus somatic protoscolex antigens for serological follow-up of young patients surgically treated for cystic echinococcosis. J Clin Microbiol 46: 1631-1640.
21. McVie A, Ersfeld K, Rogan MT, Craig PS, (1997) Expression and immunological characterization of Echinococcus granulosus recombinant antigen B for IgG4 subclass detection in human cystic echinococcosis. Acta Trop 67: 19-35.
22. Mamuti W, Yamasaki H, Sako Y, Nakao M, Xiao N, et al. (2004) Molecular cloning, expression, and serological evaluation of an 8-kilodalton subunit of antigen B from Echinococcus multilocularis. J Clin Microbiol 42: 1082-1088.
23. Li T, Chen X, Ren Z, Qiu J, Qiu D, et al. (2010) Widespread co-endemicity of human cystic and alveolar echinococcosis on the eastern Tibetan Plateau, northwest Sichuan/ southeast Qinghai, China. Act Tropica 113: 248-256.
24. World Health Organization Informal Working Group (2003) International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop 85: 253-261.
25. Morris DL, Dykes PW, Dickson B, (1983) Albendazole in hydatid disease. Brit Med J 286: 103-204.
26. Saimot AG, Couland JP, (1985) Treatment of echinococcosis (E.granulosus) with albendazole. Bull Soc Pathol Exot Filiales 78 (Suppl): 718-722.
27. Todorov T, Mechkov G, Vutova K, Georgiev P, Lazarova I, et al. (1992) Factors influencing the response to chemotherapy in human echinococcosis. Bull World Health Organzition 70: 347-358.
28. Gil-Grande LA, Rodriguez-Cabeiro F, Prieto JG, Sánchez-Ruano JJ, Brasa C, et al. (1993) Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 342: 1269-1272.
29. Horton RJ, (1997) Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop 64: 79-93.
30. Franchi C, Di Vico B, Teggi A, (1999) Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. Clin Infect Dis 29: 304-309.
31. Vutova k, Medhkov G, Vachkov P, Petkov R, Georgiev P, et al. (1999) Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration. Ann Trop Med Parasitol 93: 357-365.
32. Romig T, Zeyhle E, Macpherson CN, Rees PH, Were JB, (1986) Cyst grow and spontaneous cure in hydatid disease. Lancet 1: 861.
33. Larrieu E, Carpio MD, Salvitti JC, Mercapide C, Sustersic J, et al. (2004) Ultrasonographic diagnosis and medical treatment of human cystic echinococcosis in asymptomatic school age carriers: 5 year of follow-up. Acta Trop 91: 5-13.
34. Lightowlers MW, Liu D, Haralambous A, Rickard MD, (1989) Subunit composition and specificity of major cyst fluid antigens of Echinococcus granulosus. Mol Biochem Parasitol 37: 171-182.
35. Leggatt GR, Yang W, McManus DP, (1992) Serological evaluation of the 12 kDa subunit of antigen B in Echinococcus granulosus cyst fluid by immunoblot analysis. Trans R Soc Trop Med Hyg 86: 1-4.
36. Ioppolo S, Notargiacomo S, Profumo E, Franchi C, Ortona E, et al. (1996) Immunological responses to antigen B from Echinococcus granulosus cyst fluid in hydatid patients. Parasite Immunol 18: 571-578.
37. Ito A, Ma L, Schantz PM, Gottstein B, Liu YH, et al. (1999) Differential serodiagnosis for cystic and alveolar echinococcosis using fractions of Echinococcus granulosus cyst fluid (antigen B) and Echinococcus multilocularis protoscolex (Em18). Am J Trop Med Hyg 60: 188-192.
38. Li T, Ito A, Chen X, Sako Y, Qiu J, et al. (2010) Specific IgG responses to recombinant antigen B and Em18 in cystic and alveolar echinococcosis in China. Clin Vaccine Immunol 17: 470-476.
39. Horton J, (2003) Albendazole for the treatment of echinococcosis. Fundam Clin Pharmacol 17: 205-212.
40. Venkatesan P, (1998) Albendazole. J Antimicrob Chemother 41: 145-147.
41. Opatrny L, Prichard R, Snell L, Maclean JD, (2005) Death related to albendazole-induced pancytopenia: case report and review. Am J Trop Med Hyg 72: 291-294.
42. Horton RJ, (1989) Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 83: 97-102.
43. Kern P, (2003) Echinococcus granulosus infection: clinical presentation, medical treatment and outcome. Langenbecks Arch Surg 388: 413-20.